GCC Generic Drug Market Overview:
The GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028. A generic drug contains similar chemical substances, performance characteristics, dosage form, route of administration, quality, safety, strength, and intended use as a patented brand-name drug. These drugs are permitted for sale only after the patents on the original drugs expire. Generic drug manufacturers perform studies and experiments in a laboratory to justify the similarity between the two drugs. The studies are then analyzed by the food and drug administration (FDA) scientists for approval. When compared to brand-name drugs, generic drugs cost less as they do not need extensive research or animal and clinical studies to demonstrate safety and effectiveness. Paracetamol, amoxicillin, ofloxacin, and cefixime are some of the commonly available generic drugs. In the GCC, generic drugs are witnessing a significant surge in demand on account of the increasing consumer awareness regarding the benefits offered by the drugs.
The rapid expiry of patented brand-name drugs and the cost-effective prices of generic drugs are some of the key factors creating a positive outlook for the market in the GCC. This is further bolstered by the surging prevalence of chronic lifestyle diseases, such as diabetes and obesity, due to sedentary lifestyles and shifting dietary patterns. Moreover, a significant expansion in the pharmaceutical industry has enabled the easy availability of generic drugs and healthcare services at affordable prices, which is acting as another growth-inducing factor. Additionally, regional governments are undertaking various initiatives to promote the adoption of generic drugs, which is accelerating the market growth. For instance, in Abu Dhabi, the government has mandated the dispersal of generic drugs as a first choice across all pharmacies to provide improved healthcare services to their citizens. Furthermore, key market manufacturers are investing heavily in advanced technologies to enhance drug delivery systems, such as the advent of self-injection devices, which is positively supporting the market growth in the region. Apart from this, the increasing geriatric population, rising consumer per capita income, and burgeoning healthcare expenditure are providing an impetus to the market growth.
Beginning with a regional overview, the report explores the dynamics that have a strong influence on the GCC generic drug market and can also impact its future growth. Taking 2022 as the base year, the report covers historical market scenario from 2017-2022 and provides forecasts till 2028. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry. On a regional basis, the report examines the GCC generic drug market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. For each of these regions, the report studies the GCC generic drug market in detail for latest trends, outlook and opportunities.
The report analyses the competitive structure of the GCC generic drug industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the GCC generic drug industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the GCC generic drug industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the GCC generic drug industry. Furthermore, the value chain analysis of the GCC generic drug industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution.
Key Market Segments:
The GCC generic drug market has been analysed as followed:
Regional Insights:
Country-wise, the market has been segmented into Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. Amongst these, Saudi Arabia represents the largest market, accounting for majority of the GCC region.
Competative Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Highlights of the GCC generic drug Market Report:
Report Customisation:
The GCC generic drug market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs
1 Preface
2 Scope and Methodology
2.1 Objectives of the study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Breakup by Drug Delivery
5.5 Market Forecast
6 GCC Generic Drug Industry
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Region
6.5 Market Forecast
6.6 SWOT Analysis
6.6.1 Overview
6.6.2 Strengths
6.6.3 Weaknesses
6.6.4 Opportunities
6.6.5 Threats
6.7 Value Chain Analysis
6.7.1 Overview
6.7.2 Research and Development
6.7.3 Raw Material Procurement
6.7.4 Manufacturing
6.7.5 Marketing
6.7.6 Distribution
6.8 Porter’s Five Forces Analysis
6.8.1 Overview
6.8.2 Bargaining Power of Buyers
6.8.3 Bargaining Power of Suppliers
6.8.4 Degree of Competition
6.8.5 Threat of New Entrants
6.8.6 Threat of Substitutes
6.9 Key Success and Risk Factors for Manufacturers
7 Performance of Key Regions
7.1 Saudi Arabia
7.1.1 Market Performance
7.1.2 Market Forecast
7.1.3 Key Players
7.1.4 Regulatory Process for Generics Drug Industry in Saudi Arabia
7.2 UAE
7.2.1 Market Performance
7.2.2 Market Forecast
7.2.3 Key Players
7.2.4 Regulatory Process for Generics Drug Industry in UAE
7.3 Kuwait
7.3.1 Market Performance
7.3.2 Market Forecast
7.3.3 Regulatory Process for Generics Drug Industry in Kuwait
7.4 Qatar
7.4.1 Market Performance
7.4.2 Market Forecast
7.4.3 Regulatory Process for Generics Drug Industry in Qatar
7.5 Bahrain
7.5.1 Market Performance
7.5.2 Market Forecast
7.5.3 Regulatory Process for Generics Drug Industry in Bahrain
7.6 Oman
7.6.1 Market Performance
7.6.2 Market Forecast
7.6.3 Regulatory Process for Generics Drug Industry in Oman
8 Competitive Landscape
8.1 Competitive Structure
8.2 Market Share of Key Players
9 Generic Drug Manufacturing Process
9.1 Product Overview
9.2 Detailed Process Flow
9.3 Various Types of Unit Operations Involved
9.4 Mass Balance and Raw Material Requirements
10 Project Details, Requirements and Costs Involved
10.1 Land Requirements and Expenditures
10.2 Construction Requirements and Expenditures
10.3 Plant Machinery
10.4 Machinery Pictures
10.5 Raw Material Requirements and Expenditures
10.6 Packaging Requirements and Expenditures
10.7 Transportation Requirements and Expenditures
10.8 Utility Requirements and Expenditures
10.9 Manpower Requirements and Expenditures
10.10 Other Capital Investments
11 Loans and Financial Assistance
12 Project Economics
12.1 Capital Cost of the Project
12.2 Techno-Economic Parameters
12.3 Product Pricing and Margins across Various Levels of the Supply Chain
12.4 Taxation and Depreciation
12.5 Income Projections
12.6 Expenditure Projections
12.7 Financial Analysis
12.8 Profit Analysis
13 Key Player Profiles
List of Figures
Figure 1: Global: Generic Drug Market: Key Market Drivers and Challenges
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2017-2022
Figure 3: Global: Generic Drug Market: Breakup by Region (in %), 2022
Figure 4: Global: Generic Drug Market: Breakup by Drug Delivery (in %), 2022
Figure 5: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2023-2028
Figure 6: GCC: Generic Drug Market: Sales Value Trends (in Billion US$), 2017-2022
Figure 7: GCC: Generic Drug Market: Breakup by Region (in %), 2022
Figure 8: GCC: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2023-2028
Figure 9: GCC: Generic Drug Industry: SWOT Analysis
Figure 10: GCC: Generic Drug Industry: Value Chain Analysis
Figure 11: GCC: Generic Drug Industry: Porter’s Five Forces Analysis
Figure 12: Saudi Arabia: Generic Drug Market: Sales Value Trends (in Million US$), 2017-2022
Figure 13: Saudi Arabia: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2023-2028
Figure 14: Saudi Arabia: Generic Drug Market: Breakup by Key Players (in %), 2022
Figure 15: UAE: Generic Drug Market: Sales Value Trends (in Million US$), 2017-2022
Figure 16: UAE: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2023-2028
Figure 17: UAE: Generic Drug Market: Breakup by Key Players (in %), 2022
Figure 18: Kuwait: Generic Drug Market: Sales Value Trends (in Million US$), 2017-2022
Figure 19: Kuwait: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2023-2028
Figure 20: Qatar: Generic Drug Market: Sales Value Trends (in Million US$), 2017-2022
Figure 21: Qatar: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2023-2028
Figure 22: Bahrain: Generic Drug Market: Sales Value Trends (in Million US$), 2017-2022
Figure 23: Bahrain: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2023-2028
Figure 24: Oman: Generic Drug Market: Sales Value Trends (in Million US$), 2017-2022
Figure 25: Oman: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2023-2028
Figure 26: GCC: Generic Drug Market: Breakup by Key Players (in %), 2022
Figure 27: Generic Drug Manufacturing: Detailed Process Flow
Figure 28: Generic Drug Manufacturing Process: Conversion Rate of Products
Figure 29: Generic Drug Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 30: Generic Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 31: Generic Drug Production: Manufacturing Cost Breakup (in %)
Figure 32: Generic Drug Production: Price Structure Analysis
List of Tables
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 2: GCC: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 3: GCC: Generic Drug Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 4: Generic Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 5: Generic Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 6: Generic Drug Manufacturing Plant: Costs Related to Machinery (in US$)
Table 7: Generic Drug Manufacturing Plant: Raw Material Requirements
Table 8: Generic Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 9: Generic Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 10: Details of Financial Assistance Offered by Financial Institutions
Table 11: Generic Drug Manufacturing Plant: Capital Costs (in US$)
Table 12: Generic Drug Manufacturing Plant: Techno-Economic Parameters
Table 13: Generic Drug Manufacturing Plant: Taxation and Depreciation
Table 14: Generic Drug Manufacturing Plant: Income Projections (in US$)
Table 15: Generic Drug Manufacturing Plant: Expenditure Projections (in US$)
Table 16: Generic Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 17: Generic Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Table 18: Generic Drug Manufacturing Plant: Profit and Loss Account
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC intravenous solutions market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.